These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25649765)

  • 1. BMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugs.
    Fox JL; Storey A
    Cancer Res; 2015 Apr; 75(7):1345-55. PubMed ID: 25649765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine dephosphorylation is required for Bak activation in apoptosis.
    Fox JL; Ismail F; Azad A; Ternette N; Leverrier S; Edelmann MJ; Kessler BM; Leigh IM; Jackson S; Storey A
    EMBO J; 2010 Nov; 29(22):3853-68. PubMed ID: 20959805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation.
    Zhang Z; Zhu W; Zhang J; Guo L
    Cancer Biol Ther; 2011 Apr; 11(7):690-8. PubMed ID: 21339702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells.
    Dai H; Ding H; Meng XW; Peterson KL; Schneider PA; Karp JE; Kaufmann SH
    Genes Dev; 2015 Oct; 29(20):2140-52. PubMed ID: 26494789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
    Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X
    Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
    Olejniczak SH; Hernandez-Ilizaliturri FJ; Clements JL; Czuczman MS
    Clin Cancer Res; 2008 Mar; 14(5):1550-60. PubMed ID: 18316580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells.
    Choi SY; Kim MJ; Kang CM; Bae S; Cho CK; Soh JW; Kim JH; Kang S; Chung HY; Lee YS; Lee SJ
    J Biol Chem; 2006 Mar; 281(11):7049-59. PubMed ID: 16410245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAK multimerization for apoptosis, but not bid binding, is inhibited by negatively charged residue in the BAK hydrophobic groove.
    Azad A; Storey A
    Mol Cancer; 2013 Jun; 12():65. PubMed ID: 23782464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-mediated Bak activation and cytochrome c release during intrinsic apoptotic cell death in Jurkat cells.
    Shawgo ME; Shelton SN; Robertson JD
    J Biol Chem; 2008 Dec; 283(51):35532-8. PubMed ID: 18927073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Wesarg E; Hoffarth S; Wiewrodt R; Kröll M; Biesterfeld S; Huber C; Schuler M
    Int J Cancer; 2007 Dec; 121(11):2387-94. PubMed ID: 17688235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
    Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
    PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.
    Castilla C; Congregado B; Chinchón D; Torrubia FJ; Japón MA; Sáez C
    Endocrinology; 2006 Oct; 147(10):4960-7. PubMed ID: 16794010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.
    Ling YH; Lin R; Perez-Soler R
    Mol Pharmacol; 2008 Sep; 74(3):793-806. PubMed ID: 18524889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer.
    Meiler J; Guyot M; Hoffarth S; Wesarg E; Höhn Y; Breitenbuecher F; Schuler M
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1385-94. PubMed ID: 22488173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins.
    Beverly LJ; Howell LA; Hernandez-Corbacho M; Casson L; Chipuk JE; Siskind LJ
    Biochem J; 2013 May; 452(1):111-9. PubMed ID: 23480852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VDAC2 inhibits BAK activation and mitochondrial apoptosis.
    Cheng EH; Sheiko TV; Fisher JK; Craigen WJ; Korsmeyer SJ
    Science; 2003 Jul; 301(5632):513-7. PubMed ID: 12881569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The additional loss of Bak and not the lack of the protein tyrosine kinase p56/Lck in one JCaM1.6 subclone caused pronounced apoptosis resistance in response to stimuli of the intrinsic pathway.
    Rudner J; Mueller AC; Matzner N; Huber SM; Handrick R; Belka C; Jendrossek V
    Apoptosis; 2009 May; 14(5):711-20. PubMed ID: 19343496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bak apoptotic function is not directly regulated by phosphorylation.
    Tran VH; Bartolo R; Westphal D; Alsop A; Dewson G; Kluck RM
    Cell Death Dis; 2013 Jan; 4(1):e452. PubMed ID: 23303126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.
    Park D; Anisuzzaman ASM; Magis AT; Chen G; Xie M; Zhang G; Behera M; Sica GL; Ramalingam SS; Owonikoko TK; Deng X
    Theranostics; 2021; 11(17):8500-8516. PubMed ID: 34373755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.